Overblog Alle Blogs
Edit post Folge diesem Blog Administration + Create my blog
MENU

Mein Blog umfasst die aktuellesten News, Forschungsleistung, neuesten Produkte und Service von Sino Biological Inc. und die aktuelle News von Life Sciences. Sie können sich hier wissenschaftlich informieren.Willkommen zu meinem Blog.Viel Spaß!

Werbung

Cynomolgus CCL17 / TARC Protein (His Tag)

Sino Biological Inc. liefert Cynomolgus CCL17 / TARC Protein (His Tag) mit höherer Qualität und günstiger Kosten im Vergleich mit anderen globalen Lieferanten.

Weitere Informationen über Cynomolgus CCL17 / TARC Protein (His Tag) lesen Sie bitte: http://www.sinobiological.com/CCL17-TARC-Protein-g-10278.html

Produkt-Information von CCL17 / TARC Protein

Synonym CCL17, TARC
Protein Construction

A DNA sequence encoding the cynomolgus CCL17 (Q8HYP9) (Met1-Ser94) was expressed with a polyhistidine tag at the C-terminus.

Source Cynomolgus
Expression Host Baculovirus-Insect cells

QC Testing von CCL17 / TARC Protein

Purity > 95 % as determined by SDS-PAGE SDS-PAGE:
SDS-PAGE

CCL17 protein

Endotoxin < 1.0 EU per μg of the protein as determined by the LAL method
Stability Samples are stable for up to twelve months from date of receipt at -70℃
Predicted N terminal Ala 24
Molecular Mass

The recombinant heterodimer of cynomolgus CCL17 comprises 81 amino acids and has a calculated molecular mass of 9.5 KDa. The apparent molecular mass of the protein is approximately 10 KDa respectively in SDS-PAGE.

Formulation Lyophilized from sterile 20mM Tris, 500mM NaCl,  pH 7.4, 10% gly.
  1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.

Usage Guide von CCL17 / TARC Protein

Storage Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.

Verwandte Produkte & Themen von CCL17 / TARC Protein

Related Areas:

Immunology>>Cytokine & Receptor>>Chemokine & Receptor>>CCL17/TARC

Immunology>>Innate Immunity>>Monocyte/Macrophage>>Macrophage Marker>>CCL17/TARC

Proteins:
Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
CCL17/TARC Human CCL17/TARC Protein, Recombinant 10233-H08B
CCL17/TARC Human CCL17/TARC Protein, Recombinant, Native 10233-HNAB
CCL17/TARC Mouse CCL17 / TARC Protein, Recombinant 50046-MNAB
CCL17/TARC Cynomolgus CCL17 / TARC Protein, Recombinant 90077-C08B
Antibodies:
Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Human CCL17/TARC WB, ELISA

CCL17 / TARC Antibody (Antigen Affinity Purified)

10233-RP02
Human CCL17/TARC WB, ELISA

CCL17 / TARC Antibody

10233-MM03

Beschreibung von CCL17 / TARC Protein

C-C motif chemokine 17, also known as CC chemokine TARC, Small-inducible cytokine A17, Thymus and activation-regulated chemokine, CCL17 and SCYA17, is a secreted protein which belongs to the intercrine beta (chemokine CC) family. Chemokines are known to regulate the steady-state and inflammatory migration of cutaneous dendritic cells (DCs). The beta-chemokine CCL17, a ligand of CCR4, is inducibly expressed in a subset of DCs and is strongly up-regulated in atopic diseases. CCL17 / SCYA17 is constitutively expressed in the thymus and is produced by dendritic cells (DC), endothelial cells, keratinocytes (KC) and fibroblasts. CCL17 / SCYA17 is expressed at high levels in thymus and at low levels in the lung, colon and small intestine. CCL17 / SCYA17 is a chemotactic factor for T-lymphocytes but not monocytes or granulocytes. It may play a role in T-cell development in thymus and in trafficking and activation of mature T-cells. CCL17 / SCYA17 binds to CCR4.Chemokine receptor CCR4 and its ligands (CCL17 and CCL22) are important for the recruitment of memory T cells into the skin in various cutaneous immune disease.

References

  1. Belperio JA. et al., 2004, J Immunol. 173 (7): 4692-8.
  2. Carpenter KJ. et al., 2005, Infect Immun. 73 (11): 7198-207.
  3. Saeki H. et al., 2006, J Dermatol Sci. 43 (2): 75-84.
  4. Niens M. et al., 2008, Br J Haematol. 140 (5): 527-36.
  5. Stutte S. et al., 2010, Proc Natl Acad Sci. 107 (19): 8736-41.
Werbung
Zurück zu Home
Diesen Post teilen
Repost0
Um über die neuesten Artikel informiert zu werden, abonnieren:
Kommentiere diesen Post